M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib et al., Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era, Circulation, vol.122, issue.2, pp.156-163, 2010.
DOI : 10.1161/CIRCULATIONAHA.109.911818

M. Handoko, F. De-man, C. Allaart, W. Paulus, and N. Westerhof, Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart, European Respiratory Review, vol.19, issue.115, pp.72-82, 2010.
DOI : 10.1183/09059180.00007109

E. Eichhorn and M. Bristow, Medical Therapy Can Improve the Biological Properties of the Chronically Failing Heart: A New Era in the Treatment of Heart Failure, Circulation, vol.94, issue.9, pp.2285-2296, 1996.
DOI : 10.1161/01.CIR.94.9.2285

A. Ciarka, V. Doan, S. Velez-roa, R. Naeije, and P. Van-de-borne, Prognostic Significance of Sympathetic Nervous System Activation in Pulmonary Arterial Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.181, issue.11, pp.1269-1275, 2010.
DOI : 10.1164/rccm.200912-1856OC

F. De-man, M. Handoko, J. Van-ballegoij, I. Schalij, S. Bogaards et al., Bisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension, Circulation: Heart Failure, vol.5, issue.1, pp.97-105, 2012.
DOI : 10.1161/CIRCHEARTFAILURE.111.964494

M. Nootens, E. Kaufmann, T. Rector, C. Toher, D. Judd et al., Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels, Journal of the American College of Cardiology, vol.26, issue.7, pp.1581-1585, 1995.
DOI : 10.1016/0735-1097(95)00399-1

S. Velez-roa, A. Ciarka, B. Najem, J. Vachiery, R. Naeije et al., Increased Sympathetic Nerve Activity in Pulmonary Artery Hypertension, Circulation, vol.110, issue.10, pp.1308-1312, 2004.
DOI : 10.1161/01.CIR.0000140724.90898.D3

W. Abraham, M. Raynolds, D. Badesch, K. Wynne, B. Groves et al., Angiotensin-converting enzyme DD genotype in patients with primary pulmonary hypertension: increased frequency and association with preserved haemodynamics, Journal of the Renin-Angiotensin-Aldosterone System, vol.7, issue.1, pp.27-30, 2003.
DOI : 10.3317/jraas.2003.003

C. Orte, J. Polak, S. Haworth, M. Yacoub, and N. Morrell, Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension, The Journal of Pathology, vol.67, issue.3, pp.379-384, 2000.
DOI : 10.1002/1096-9896(2000)9999:9999<::AID-PATH715>3.0.CO;2-Q

M. Bader, Tissue Renin-Angiotensin-Aldosterone Systems: Targets for Pharmacological Therapy, Annual Review of Pharmacology and Toxicology, vol.50, issue.1, pp.439-465, 2010.
DOI : 10.1146/annurev.pharmtox.010909.105610

M. Burnier, Angiotensin II Type 1 Receptor Blockers, Circulation, vol.103, issue.6, pp.904-912, 2001.
DOI : 10.1161/01.CIR.103.6.904

C. Johnston, Angiotensin receptor antagonists: focus on losartan, The Lancet, vol.346, issue.8987, pp.1403-1407, 1995.
DOI : 10.1016/S0140-6736(95)92411-6

A. Ferreira, V. Shenoy, Y. Yamazato, S. Sriramula, J. Francis et al., Evidence for Angiotensin-converting Enzyme 2 as a Therapeutic Target for the Prevention of Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.179, issue.11, pp.1048-1054, 2009.
DOI : 10.1164/rccm.200811-1678OC

V. Shenoy, A. Ferreira, Y. Qi, R. Fraga-silva, C. Diez-freire et al., The Angiotensin-Converting Enzyme 2/Angiogenesis-(1???7)/Mas Axis Confers Cardiopulmonary Protection against Lung Fibrosis and Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.182, issue.8, pp.1065-1072, 2011.
DOI : 10.1164/rccm.200912-1840OC

L. Li, Y. Zhou, C. Wang, Y. Zhao, Z. Zhang et al., Src tyrosine kinase regulates angiotensin II-induced protein kinase C?? activation and proliferation in vascular smooth muscle cells, Peptides, vol.31, issue.6, pp.1159-1164, 2010.
DOI : 10.1016/j.peptides.2010.03.014

M. Alpert, T. Pressly, V. Mukerji, C. Lambert, and B. Mukerji, Short- and Long-term Hemodynamic Effects of Captopril in Patients with Pulmonary Hypertension and Selected Connective Tissue Disease, Chest, vol.102, issue.5, pp.1407-1412, 1992.
DOI : 10.1378/chest.102.5.1407

H. Ikram, A. Maslowski, M. Nicholls, E. Espiner, and F. Hull, Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension., Heart, vol.48, issue.6, pp.541-545, 1982.
DOI : 10.1136/hrt.48.6.541

B. Rondelet, F. Kerbaul, R. Van-beneden, I. Hubloue, S. Huez et al., Prevention of pulmonary vascular remodeling and of decreased BMPR-2 expression by losartan therapy in shunt-induced pulmonary hypertension, AJP: Heart and Circulatory Physiology, vol.289, issue.6, pp.2319-2324, 2005.
DOI : 10.1152/ajpheart.00518.2005

M. Okada, T. Harada, R. Kikuzuki, H. Yamawaki, and Y. Hara, Effects of Telmisartan on Right Ventricular Remodeling Induced by Monocrotaline in Rats, Journal of Pharmacological Sciences, vol.111, issue.2, pp.193-200, 2009.
DOI : 10.1254/jphs.09112FP

T. Kind, J. Marcus, G. Mauritz, M. Heymans, H. Bogaard et al., Cardioprotective effects of ramipril and losartan in right ventricular pressure overload in the rabbit: Importance of kinins and influence on angiotensin ii type 1 receptor signaling pathway Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy, Circulation J Am Coll Cardiol, vol.10458, issue.37, pp.939-9442511, 2001.

R. E. Levey, A. Coresh, J. Greene, T. Stevens, L. Zhang et al., Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate, Annals of Internal Medicine, vol.145, issue.4, pp.247-254, 2006.
DOI : 10.7326/0003-4819-145-4-200608150-00004

E. Guignabert, C. Tu, L. Izikki, M. Dewachter, L. Zadigue et al., Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22??-targeted overexpression of the serotonin transporter, The FASEB Journal, vol.23, issue.12, pp.4135-4147, 2009.
DOI : 10.1096/fj.09-131664
URL : https://hal.archives-ouvertes.fr/inserm-00499630

E. Handoko, M. Schalij, I. Kramer, K. Sebkhi, A. Postmus et al., A refined radio-telemetry technique to monitor right ventricle or pulmonary artery pressures in rats: a useful tool in pulmonary hypertension research, Pfl??gers Archiv - European Journal of Physiology, vol.136, issue.5, pp.951-959, 2008.
DOI : 10.1007/s00424-007-0334-z

E. De-man, F. Handoko, M. Van-ballegoij, J. Schalij, I. Bogaards et al., Bisoprolol Delays Progression Towards Right Heart Failure in Experimental Pulmonary Hypertension, Circulation: Heart Failure, vol.5, issue.1, pp.97-105, 2012.
DOI : 10.1161/CIRCHEARTFAILURE.111.964494

E. De-man, F. Van-hees, H. Handoko, M. Niessen, H. Schalij et al., Diaphragm Muscle Fiber Weakness in Pulmonary Hypertension, American Journal of Respiratory and Critical Care Medicine, vol.183, issue.10, pp.1411-1418, 2011.
DOI : 10.1164/rccm.201003-0354OC

E. Handoko, M. Lamberts, R. Redout, E. De-man, F. Boer et al., Right ventricular pacing improves right heart function in experimental pulmonary arterial hypertension: a study in the isolated heart, AJP: Heart and Circulatory Physiology, vol.297, issue.5, pp.1752-1759, 2009.
DOI : 10.1152/ajpheart.00555.2009

E. Handoko, M. De-man, F. Happe, C. Schalij, I. Musters et al., Opposite Effects of Training in Rats With Stable and Progressive Pulmonary Hypertension, Circulation, vol.120, issue.1, pp.42-49, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.829713

E. Brimioulle, S. Wauthy, P. Ewalenko, P. Rondelet, B. Vermeulen et al., Single-beat estimation of right ventricular end-systolic pressure-volume relationship, American Journal of Physiology - Heart and Circulatory Physiology, vol.284, issue.5, pp.1625-1630, 2003.
DOI : 10.1152/ajpheart.01023.2002

E. Westerhof, N. , N. Stergiopulos, and M. I. Noble, Snapshots of Hemdynamics: An aid for Clinical Research and Graduate Education Springer, 2005.

E. Hessel, M. Steendijk, P. Adel, B. Schutte, C. Van-der-laarse et al., Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat, AJP: Heart and Circulatory Physiology, vol.291, issue.5, pp.2424-2430, 2006.
DOI : 10.1152/ajpheart.00369.2006

. Bmchange, percentage change in body mass of the last 2 days; ?/tl, organ mass normalized for tibia length, LV+S), RV-to-LV (including septum) mass ratio